Mary Barra, CEO of General Motors, attends the annual Allen and Co. Sun Valley Media and Technology Conference at the Sun Valley Resort in Sun Valley, Idaho, on July 8, 2025. David A. Grogan | CNBC DETROIT — General Motors is on pace to be the top U.S.-traded automaker stock of 2025, as shares of… Continue reading GM’s record stock performance beats Tesla, Ford and other automakers in 2025
Tag: Morgan
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time. Interested parties may access a live webcast of the fireside… Continue reading 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
THE MEXICO FUND, INC. ISSUES ITS 2025 ANNUAL REPORT
COLUMBIA, Maryland, Dec. 29, 2025 /PRNewswire/ — The Mexico Fund, Inc. (NYSE: MXF), today issued its fiscal 2025 Annual Report for the period ended October 31, 2025. A full version of the report is available at the company´s website – www.themexicofund.com Annual Report 2025 Highlights During fiscal year 2025, the Fund’s NAV per share and… Continue reading THE MEXICO FUND, INC. ISSUES ITS 2025 ANNUAL REPORT
Waystar to Present at J.P. Morgan Healthcare Conference
LEHI, Utah and LOUISVILLE, Ky., Dec. 29, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT. Waystar will provide a live webcast… Continue reading Waystar to Present at J.P. Morgan Healthcare Conference
Testing the bookends of BMW’s supreme B58 straight-six engine
If I were to gaze into a crystal ball and predict what kinds of articles classic car magazines will be pumping out in 25 years’ time, staring back at me from within the quartz would be one letter and two numbers: B58. A few pages on the history, the birth, the need for a new… Continue reading Testing the bookends of BMW’s supreme B58 straight-six engine
To Bruges and back in a bathtub
I had to go to Bruges, and the options were either to take my old Audi A2 or get some touring miles under the wheels of the Morgan Super 3 before the weather became too cold for that sort of thing. So I opted for the Morgan, and it turned out to be a splendid… Continue reading To Bruges and back in a bathtub
Citi Sees Upside in Lear Corporation (LEA) Despite Cyclical Auto Headwinds
We recently compiled a list of the 10 Cheap Stocks With Strong Buy Ratings on Wall Street. Lear Corporation is among the cheap stocks to buy. TheFly reported on December 15 that Citigroup maintained its Buy rating on LEA and raised the price target to $146 from $136, reflecting confidence in the company’s long‑term prospects amid… Continue reading Citi Sees Upside in Lear Corporation (LEA) Despite Cyclical Auto Headwinds
A very güten Morgan: Charming Supersport is my dream daily
The view that greets a Supersport driver is one of the best in modern motordom: a long, sleek bonnet, swooping wheel arches and diminutive, spotlight-style headlamps ensure this car is characteristically true to Morgans of yore. But what sets the Supersport apart from its forebears is its ease of use, practicality and ultimately its more… Continue reading A very güten Morgan: Charming Supersport is my dream daily
Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management (CBL-0201WR Phase 2). The study will evaluate CBL-514 in combination with Zepbound® (Eli Lilly) in subjects with obesity or overweight. Efficacy endpoints include changes in abdominal… Continue reading Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Dec. 24, 2025 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 22, 2025, TransMedics granted non-qualified stock options to purchase an aggregate of 6,333 shares of its common stock and… Continue reading TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)